Vitamin Shoppe Inc (VSI)

26.85
0.73 2.79
NYSE : Services
Prev Close 26.12
Open 26.17
Day Low/High 26.10 / 26.95
52 Wk Low/High 26.02 / 34.41
Volume 153.52K
Avg Volume 269.00K
Exchange NYSE
Shares Outstanding 24.00M
Market Cap 626.90M
EPS 1.80
P/E Ratio 15.01
Div & Yield N.A. (N.A)

Latest News

Vitamin Shoppe Enters Oversold Territory (VSI)

Vitamin Shoppe Enters Oversold Territory (VSI)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

GNC Goes South After C-Suite Shake-Up

GNC Goes South After C-Suite Shake-Up

Shares in the retailer of nutritional supplements plummet on Thursday as it announces the departure of CEO Archbold after a less than two-year-long turnaround attempt.

VSI Crosses Above Average Analyst Target

VSI Crosses Above Average Analyst Target

In recent trading, shares of Vitamin Shoppe Inc have crossed above the average analyst 12-month target price of $31.38, changing hands for $31.79/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Herbalife's Correct Price; What Bill Ackman Needs: Jim Cramer’s Best Blogs

Herbalife's Correct Price; What Bill Ackman Needs: Jim Cramer’s Best Blogs

Jim Cramer talks about the what Bill Ackman needs and how to figure out Herbalife's correct price.

Bill Ackman Just Can't Seem to Catch a Break With Regulators

Bill Ackman Just Can't Seem to Catch a Break With Regulators

Shares of Herbalife jumped on Friday on news that regulators have concluded the company is not what Ackman alleged -- an illicit pyramid scheme.

Jim Cramer -- What Should You Pay for Herbalife Now?

Jim Cramer -- What Should You Pay for Herbalife Now?

You need out-and-out war between hedge fund managers and a monster squeeze to justify these prices, Cramer says.

Ackman Again Whipsawed by Herbalife, Valeant as Regulators Disappoint Pershing

Ackman Again Whipsawed by Herbalife, Valeant as Regulators Disappoint Pershing

It looks like the billionaire activist can't catch a break on these two stocks.

Cramer: Only Herbalife's Earnings Power Shows You the Correct Price

Cramer: Only Herbalife's Earnings Power Shows You the Correct Price

Anything above that, you speculate on Ackman vs. Icahn.

Commit To Buy Vitamin Shoppe At $22.50, Earn 7.2% Annualized Using Options

Commit To Buy Vitamin Shoppe At $22.50, Earn 7.2% Annualized Using Options

Investors eyeing a purchase of Vitamin Shoppe Inc stock, but cautious about paying the going market price of $30.02/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the February 2017 put at the $22.50 strike, which has a bid at the time of this writing of $1.00.

Why Shares Of 103-Year-Old Clorox Just Hit an All-Time High

Why Shares Of 103-Year-Old Clorox Just Hit an All-Time High

It all comes down to results.

"Commit To Fit" On May 14th With The Vitamin Shoppe®

All Stores Nationwide will Host a Share the Health Expo®

Clorox, Consumer Products Should Shine Amid Jobs Slowdown, Cramer Says

Clorox, Consumer Products Should Shine Amid Jobs Slowdown, Cramer Says

Procter & Gamble and Johnson & Johnson may also be good buys according to TheStreet's founded.

Stock To Watch: Vitamin Shoppe (VSI) In Perilous Reversal

Stock To Watch: Vitamin Shoppe (VSI) In Perilous Reversal

Trade-Ideas LLC identified Vitamin Shoppe (VSI) as a "perilous reversal" (up big yesterday but down big today) candidate

Clorox CEO: Why I Spent $295 Million for a Digestive Health Company

Clorox CEO: Why I Spent $295 Million for a Digestive Health Company

The consumer products giant's move into faster-growing health and wellness products continues to pay dividends.

Don't Be Tempted on the GNC Turnaround

The strategic alternative announcement is smoke and mirrors.

GNC Weighs Selling Itself -- Who Should Buy It?

GNC Weighs Selling Itself -- Who Should Buy It?

The nutritional supplements retailer would be an attractive target for a private equity firm, but a merger with a big rival could also make sense.

Noteworthy Thursday Option Activity: VSI, SGI, MFRM

Noteworthy Thursday Option Activity: VSI, SGI, MFRM

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Vitamin Shoppe Inc , where a total volume of 1,924 contracts has been traded thus far today, a contract volume which is representative of approximately 192,400 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 71.7% of VSI's average daily trading volume over the past month, of 268,250 shares.

Interesting VSI Put And Call Options For November 18th

Interesting VSI Put And Call Options For November 18th

Investors in Vitamin Shoppe Inc saw new options begin trading this week, for the November 18th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 231 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Vitamin Shoppe Stock Sees Short Interest Increase 11.3%

Vitamin Shoppe Stock Sees Short Interest Increase 11.3%

The most recent short interest data has been released by the NASDAQ for the 03/15/2016 settlement date, which shows a 552,054 share increase in total short interest for Vitamin Shoppe Inc , to 5,449,131, an increase of 11.27% since 03/01/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.